Drug Discovery Is The Process By Which New Medications Are Designed And Identified For Commercial Utilization. Drug Discovery Is An Important And Lengthy Process That Involves Drug Design And Research, Target Identification, Target Validation, Lead Generation, Lead Optimization, Pharmacology, Toxicology, Pre-Clinical Trial Testing, Clinical Trials, Drug Approval, And Commercialization. The Initial Stages Of Drug Discovery Involve Drug Design And Research, Wherein A Wide Variety Of Chemical Molecules Are Synthesized And Tested. Computational Approaches Are Widely Used To Design And Modify Molecules That Match Specific Targets. The Information From This Research Is Then Used To Identify Biologically Relevant Targets That Could Be Influenced With A Drug Treatment. Once A Target Has Been Identified, The Process Moves To Target Validation. Here, Further Validation Techniques Are Utilized To Assess The Biological Relevance And The Clinical Potential Of That Target. Lead Generation And Lead Optimization Is The Next Step Of The Process. Through The Testing Of Tens Of Thousands Of Low-Potency Compounds, Molecules With Potential Therapeutic Effects Are Identified And Optimized To Enhance Bioavailability And Overall Potency. Pharmacology And Toxicology Are Then Used To Evaluate The Safety, Efficacy, And Side Effects Of The Identified Compounds In Pre-Clinical Trials. The Successful Outcomes Of These Pre-Clinical Studies Can Then Be Moved To Clinical Trials. Here, The Effects Of The New Drug Are Tested On Individuals To Further Assess Its Efficacy And Safety. If These Trials Prove Successful, The Drug Can Then Be Filed For Approval, After Which It Is Introduced Into The Market. Overall, Drug Discovery Is A Complex But Necessary Process For The Development Of New And Commercialized Drugs. Through The Progressive Stages Of Drug Design, Target Identification, Lead Generation, And Clinical Trials, Many New Medications Are Developed And Released Yearly.
Title : Eliminating implant failure in humans with nano chemistry: 30,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Nutrient and heavy metal loads from the Ribeiras to Coastal zones: A land-ocean continuum perspective in Madeira Island
Aracelis Del Carmen Narayan Rajnauth, University of Porto, Portugal
Title : Prospective polyoxometalate-based covalent organic framework heterogeneous catalysts
Arash Ebrahimi, Comenius University Bratislava, Slovakia, Slovenia
Title : De novo molecular design and bioactivity prediction of novel hexahydroquinolines as transmission-blocking PfCDPK4 inhibitors
Gbolahan O Oduselu, University of Ghana, Ghana
Title : Expanding and improve the 2D periodic law of Менделееь elements, and construct the 3D periodic law of elements
Zhongsheng Lee, Zhengzhou Commercial Technician College, China
Title : Advances in plasma-based radioactive waste treatment
Hossam A Gabbar, Ontario Tech University, Canada